PT Esa Medika Mandiri Tbk Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	454,636	384,935	172,981
Revenue Growth (YoY)	18.11%	122.53%	-
Cost of Revenue	291,848	250,018	84,881
Gross Profit	162,788	134,917	88,100
Selling, General & Admin	95,947	94,317	78,946
Operating Expenses	95,947	94,317	78,946
Operating Income	66,841	40,599	9,154
Interest Expense	-30,439	-29,513	-22,633
Earnings From Equity Investments	4,101	1,626	-
Currency Exchange Gain (Loss)	-387.79	-378.35	-95.59
Other Non Operating Income (Expenses)	2,975	1,502	14,408
Pretax Income	43,090	13,836	833.23
Income Tax Expense	10,650	2,581	-106.19
Earnings From Continuing Operations	32,440	11,255	939.42
Minority Interest in Earnings	1,692	-246.23	-
Net Income	34,132	11,009	939.42
Net Income to Common	34,132	11,009	939.42
Net Income Growth	210.05%	1071.86%	-
Shares Outstanding (Basic)	1,220	1,220	1,220
Shares Outstanding (Diluted)	1,220	1,220	1,220
EPS (Basic)	27.98	9.02	0.77
EPS (Diluted)	27.98	9.02	0.77
EPS Growth	210.05%	1071.86%	-
Free Cash Flow	-34,113	51,215	-93,942
Free Cash Flow Per Share	-27.96	41.98	-77.00
Gross Margin	35.81%	35.05%	50.93%
Operating Margin	14.70%	10.55%	5.29%
Profit Margin	7.51%	2.86%	0.54%
Free Cash Flow Margin	-7.50%	13.30%	-54.31%
EBITDA	84,232	58,868	25,561
EBITDA Margin	18.53%	15.29%	14.78%
D&A For EBITDA	17,391	18,269	16,407
EBIT	66,841	40,599	9,154
EBIT Margin	14.70%	10.55%	5.29%
Effective Tax Rate	24.72%	18.65%	-